chr3-123346931-A-G

Variant summary

Our verdict is . The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_183357.3(ADCY5):​c.1406+851T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.193 in 151,998 control chromosomes in the GnomAD database, including 3,061 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3061 hom., cov: 31)

Consequence

ADCY5
NM_183357.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.42

Publications

247 publications found
Variant links:
Genes affected
ADCY5 (HGNC:236): (adenylate cyclase 5) This gene encodes a member of the membrane-bound adenylyl cyclase enzymes. Adenylyl cyclases mediate G protein-coupled receptor signaling through the synthesis of the second messenger cAMP. Activity of the encoded protein is stimulated by the Gs alpha subunit of G protein-coupled receptors and is inhibited by protein kinase A, calcium and Gi alpha subunits. Single nucleotide polymorphisms in this gene may be associated with low birth weight and type 2 diabetes. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
ADCY5 Gene-Disease associations (from GenCC):
  • dyskinesia with orofacial involvement
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • dyskinesia with orofacial involvement, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AD, SD Classification: STRONG Submitted by: G2P, PanelApp Australia
  • neurodevelopmental disorder with hyperkinetic movements and dyskinesia
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial dyskinesia and facial myokymia
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • choreatic disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_183357.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_183357.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADCY5
NM_183357.3
MANE Select
c.1406+851T>C
intron
N/ANP_899200.1O95622-1
ADCY5
NM_001378259.1
c.1406+851T>C
intron
N/ANP_001365188.1A0A8V8TP58
ADCY5
NM_001199642.1
c.356+851T>C
intron
N/ANP_001186571.1O95622-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADCY5
ENST00000462833.6
TSL:1 MANE Select
c.1406+851T>C
intron
N/AENSP00000419361.1O95622-1
ADCY5
ENST00000850916.1
c.1568+851T>C
intron
N/AENSP00000520999.1A0ABJ7H376
ADCY5
ENST00000699718.1
c.1406+851T>C
intron
N/AENSP00000514543.1A0A8V8TP58

Frequencies

GnomAD3 genomes
AF:
0.193
AC:
29294
AN:
151878
Hom.:
3057
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.151
Gnomad AMI
AF:
0.183
Gnomad AMR
AF:
0.261
Gnomad ASJ
AF:
0.164
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.198
Gnomad FIN
AF:
0.161
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.225
Gnomad OTH
AF:
0.165
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.193
AC:
29310
AN:
151998
Hom.:
3061
Cov.:
31
AF XY:
0.189
AC XY:
14066
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.151
AC:
6258
AN:
41470
American (AMR)
AF:
0.261
AC:
3986
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
569
AN:
3468
East Asian (EAS)
AF:
0.00271
AC:
14
AN:
5164
South Asian (SAS)
AF:
0.199
AC:
956
AN:
4812
European-Finnish (FIN)
AF:
0.161
AC:
1701
AN:
10550
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.225
AC:
15269
AN:
67948
Other (OTH)
AF:
0.162
AC:
341
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1217
2434
3652
4869
6086
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.208
Hom.:
14631
Bravo
AF:
0.196
Asia WGS
AF:
0.0960
AC:
332
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
CADD
Benign
17
DANN
Benign
0.69
PhyloP100
2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.